Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 – (09-12-02)

Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Clinical Outcome After Percutaneous Coronary Intervention Isn’t it a little disappointing that, while many clinicians don’t even realize that homocysteine is an independent risk factor for cardiovascular disease, we have moved beyond acceptance to clinical outcomes. The fact that an intervention as […]

Novel Cardiovascular Risk Factors: Do They Add Value to Your Practice? – (01-27-03)

Novel Cardiovascular Risk Factors: Do They Add Value to Your Practice? These people never cease to amaze me. Here is the overview of this editorial: CRP is known to be a risk factor for CVD…There is not enough evidence to support interventions to lower CRP levels….We don’t know how to lower CRP levels….So, overall it’s […]

High insulin and homocysteine increases ADMA levels – (02-03-03)

IV L-Arginine Infusion Decreases Endothelin-1 Levels and Improves Endothelial Function in Patients w/ Angina and Normal Coronary Arteriograms — Correlation w/ Asymmetric Dimethylarginine Levels I know this title seems awfully long, but I will use this article to demonstrate an important, developing concept in regards to hypertension and CVD. Asymmetrical dimethylarginine (ADMA) is a compound […]

Age-specific relevance of usual blood pressure to vascular mortality – (12-19-02)

Age-specific relevance of usual blood pressure to vascular mortality An article like this can be a major eye-opener for many clinicians. I see many patients with “treated” hypertension in the area of 150 systolic. This has always bothered me, but pharmaceutical intervention does have its limits. This study finds that BP above 115 have a […]